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All  patients  said  that  the  project  should  be  continued  and
expanded.
The  present  data2,4 and  this  study  suggest  that  singing
does  produce  speciﬁc  beneﬁts  and  that  participation  in
singing  classes  should  be  encouraged  where  these  are  avail-
able.
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Pleural adenosine deaminase
in  the diagnostic workup of
tuberculous pleural effusion
Adenosina deaminase do liquido pleural na
abordagem diagnóstica do derrame pleural
tuberculoso
To  the  Editor,
Adenosine  deaminase  (ADA)  has  been  promoted  as  a  quick,
efﬁcient  and  cost-effective  method  in  the  diagnosis  of  tuber-
culous  effusions.1 However,  the  predictive  parameters  of
ADA,  in  the  diagnostic  workup  of  tuberculous  effusions,
depend  on  the  prevalence  of  the  disease  in  the  population2
and  no  such  analysis  has  been  published  in  Portugal,  a  coun-
try  of  intermediate  tuberculosis  (TB)  incidence  (25.9  per
100,000  in  2010).3
In  response  to  this  situation,  we  carried  out  a  cross-
sectional  analysis  over  a  4-year  period,  beginning  in  January
2006,  in  which  we  evaluated  pleural  ﬂuid  results  from  all
patients  admitted  to  our  department  with  a  pleural  effusion
of  unknown  etiology.  Only  the  results  obtained  from  the  ﬁrst
thoracocentesis  were  included  and  samples  from  empyema
were  excluded  from  our  analysis.  Pleural  ADA  was  measured
using  Giusti’s  colorimetric  method.  Mann--Whitney  test  was
performed  to  compare  medians  and  a  Receiver  Operating
Curve  (ROC)  was  used  to  determine  the  predictive  param-
eters  of  different  cutoffs.  Prism  6  from  Graphpad  Software
was  used  for  the  statistical  analysis.
A  total  of  107  pleural  samples  were  analyzed,  including
TB  (n  =  20),  malignant  (n  =  54),  parapneumonic  (n  =  20)  anda Servic¸o de  Pneumologia,  Hospital  de  Braga,  Portugal
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idiopathic  (n  =  13)  effusions.  Of  the  107  patients,  57.9%  wer
males,  median  age  was  72.5  (interquartile  range:  59.7;  80.
and  all  the  patients  were  of  European  ethnicity.  TB  pleural
effusions  were  found  to  have  the  highest  median  ADA  value
(98.55  U/L),  which  were  signiﬁcantly  higher  than  malignant
effusions  (17.99  U/L)  (p  <  0.0001)  --  the  group  with  second
highest  median  ADA  value.  Using  the  ROC  curve  we  found
that  an  ADA  cutoff  of  40.5  U/L  had  the  best  performance  in
the  diagnosis  of  pleural  TB  (see  Table  1),  with  a  sensitivity
of  95%,  speciﬁcity  of  91.55%,  positive  predictive  value  (PPV)
of  73.08%  and  negative  predictive  value  (NPV)  of  98.77%.
Seven  nontuberculous  exudates  (8.0%)  reached  the  diagnos-
tic  cutoff.  Using  a  >50%  lymphocyte  count  criteria  in  the
diagnostic  workup,  only  4.5%  nontuberculous  exudates  were
misclassiﬁed  --  2  malignant  (plasmocytoma  and  lymphoma)
and  2  parapneumonic.  The  association  of  these  two  criteria
increased  speciﬁcity  (95.40%)  and  PPV  (82.61%).  Using  an
ADA  cutoff  level  of  74.6  U/L  and  the  >50%  lymphocyte  crite-
ria  further  increased  speciﬁcity  (98.85%)  and  PPV  (93.75%),
and  only  one  (1.1%)  nontuberculous  exudate  was  misclassi-
ﬁed.
The  diagnosis  of  tuberculous  pleural  effusion  is  a  common
diagnostic  challenge  due  to  low  mycobacterial  detection
rates  and  to  the  frequent  need  for  invasive,  sometimes
technically  difﬁcult,  operator  dependent  techniques  like  the
pleural  biopsy  or  thoracoscopy.4 In  this  context,  a  rational
interpretation  of  pleural  ﬂuid  characteristics,  particularly
ADA  level  and  differential  leukocyte  count,  is  essential  to
the  diagnostic  workup.  In  our  research,  an  ADA  level  <  40  U/L
can  virtually  exclude  pleural  TB  with  a  NPV  of  98.7%,  while
an  ADA  level  >  74.6  U/L  with  >50%lymphocyte  has  a  very
high  PPV  of  93.75  and  can  thus  be  used  to  safely  con-
ﬁrm  pleural  TB  with  a  very  small  error  rate  of  1.1%.  The
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Table  1  Diagnostic  parameters  of  different  pleural  ﬂuid  characteristics.
40  U/L  40  U/L  +  >50%lymph.  74.6  U/L  +  >50%lymph.
Sensitivity  (%,  95%CI)  95.24  (76.11--99.21)  95.00  (75.05--99.17)  75.00  (50.89--91.25)
Speciﬁcity  (%,  95%CI)  91.95  (84.12--96.69)  95.40  (88.63--98.71)  98.85  (93.74--99.81)
PPV (%,  95%  CI)  74.07  (53.71--88.84)  82.61  (61.20--94.94)  93.75  (69.69--98.86)
NPV (%,  95%CI)  98.77  (93.29--99.79)  98.81  (93.52--99.80)  94.51  (87.63--98.17)
PPV: positive predictive value; NPV: negative predictive value; lymph.: lymphocytes.
performance  of  the  cutoff  value  of  40  U/L  and  the  error
rate  of  4.5%  (for  ADA  >  40  U/L  and  >50%  lymphocytes)  and
1.1%  (for  ADA  <  74.6  U/L  and  >50%  lymphocytes)  is  in  line
with  other  publications.2,5,6 In  our  analysis,  one  patient  with
pleural  TB  had  an  ADA  level  <  40  U/L;  however,  in  a  sample
collected  just  3  days  later,  ADA  level  was  now  90  U/L  which
reafﬁrms  the  diagnostic  utility  of  ADA.  Also,  as  we  have
shown,  hematological  malignancies  are  frequent  causes  of
error,  and  they  should  be  excluded  by  this  analysis  of  the
pleural  lymphocyte  populations.2,6 However,  the  usefulness
of  ADA  in  the  diagnosis  of  tuberculous  effusions  depends  on
the
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context  can  be  harmful  to  the  patient. prevalence  of  the  disease  in  the  population.2 If  tuber-
losis  is  highly  prevalent,  as  in  the  African  continent  and
utheast  Asia,  then  a  high  value  of  pleural  ADA  is  more
ely  to  be  due  to  tuberculosis,  thus  increasing  the  PPV  of
ural  ADA  in  the  diagnosis  of  pleural  TB.  If,  however,  the
ease  is  less  prevalent,  the  probability  of  a  high  ADA  being
e  to  other  causes,  such  as  cancer,  increases,  and  PPV  of
ural  ADA  is  lower.  This  is  most  evident  in  countries  with  a
 prevalence  of  tuberculosis  and  an  aging  population,  as
is  in  old  age  that  malignant  effusions  are  more  prevalent.
In  conclusion,  pleural  ADA  is  a  valuable  tool  in  the  diag-
stic  workup  of  pleural  TB  in  Portugal  and  should  routinely
 used  in  the  exclusion  or  conﬁrmation  of  TB  in  the  dif-
ential  diagnosis  of  patients  with  a  pleural  effusion  of
known  cause.  Furthermore,  in  order  to  make  a  correct
erpretation  of  its  values,  we  have  highlighted:  potential
se-positives;  the  usefulness  of  different  ADA  cutoffs  for
 exclusion  or  conﬁrmation  of  TB;  and  the  impact  of  TB
valence  on  the  predictive  parameters  of  this  tool.
US in pulmonary sarcoidosis:
hat to expect?
US (ecograﬁa endobrônquica) na sarcoidose
lmonar: o que esperar?
ar  Editor,
e  utility  of  EBUS-TBNA  in  the  diagnosis  of  sarcoidosis  has
ently  been  reported.1,2 Studies  published  have  shown  a
her  diagnostic  yield  in  favour  of  EBUS-TBNA,  compared  to
ndard  bronchoscopic  diagnostic  techniques,  particularly
 stage  I  sarcoidosis.3--6 The  main  advantages  identiﬁed,
side  the  high  diagnostic  yield,  are  the  low  complication
e  and  being  able  to  avoid  invasive  procedures,  like  medi-
inoscopy. quDiacon AH, Van de Wal BW, Wyser C, Smedema JP, Bezuiden-
hout J, Bolliger CT, et al. Diagnostic tools in tuberculous pleurisy:
a direct comparative study. Eur Respir J. 2003;22:589--91.
Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ. Diagnostic accuracy
of adenosine deaminase in tuberculous pleurisy: a meta-analysis.
Respir Med. 2008;102:744--54.
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Several  recent  editorials  reviewed  the  value  of  EBUS-
NA  in  excluding  other  diagnoses  in  patients  with
spected  sarcoidosis.  In  a recent  editorial  published  in
 Journal  of  Bronchology  and  Intervention  Pulmonology,
ich  and  colleagues  estimated  that  10,000  patients  with
ge  I  sarcoidosis  would  have  to  be  submitted  to  an
asive  diagnostic  procedure  to  identify,  at  most,  5  peo-
 with  an  alternative  pathology,  and  questioned  the
ed  for  tissue  conﬁrmation  in  asymptomatic  stage  I
coidosis.7
Among  the  series  published  with  patients  in  suspected
ge  I and  II  sarcoidosis  that  have  undergone  EBUS-TBNA,
ly  10%  obtained  an  alternative  diagnosis.8 However,  these
ernative  diagnoses  should  not  be  ignored.  A  delay  in  thisWhat  data  exists  that  is  available  in  relation  to  these
estions?
